bmiMD NAD+ nasal spray
bmiMD lists NAD+ nasal spray at $159 a month, continuing. Medication is included in that catalog price. Readers comparing nasal NAD who need bmiMD's spray format and current terms isolated from its injectable catalog. The commercial terms were checked 25 October 2026; state access, clinician approval, dispensing details, and personal suitability remain separate questions.
We may earn a commission if you start a program through links on this page. It doesn't change prices or how we sort them. Disclosure

compare bmiMD with other NAD+ nasal spray prices
A treatment-specific read of the provider: bmiMD NAD+ nasal spray
Isolate bmiMD's NAD+ nasal spray as a route-specific purchase using its own catalog record.
Readers comparing nasal NAD who need bmiMD's spray format and current terms isolated from its injectable catalog. The page therefore answers a bounded question: what bmiMD currently publishes for this exact NAD+ nasal spray offer and what still needs confirmation.
Total charge and plan duration: bmiMD NAD+ nasal spray
The published offer has both a continuing option at $159 a month, continuing and a prepaid option at $119 a month, paying $1,428 for 12 months up front. Those are different commitments. Compare the total charged today, the renewal path, and the cancellation deadline rather than treating the lowest monthly equivalent as month to month. For bmiMD's NAD+ nasal spray offer, distinguish the introductory charge, continuing charge, upfront payment and required commitment. A monthly equivalent can be useful, but only when the required payment and term remain visible beside it.
The bmiMD price source for this offer was checked on 25 October 2026. Before paying for NAD+ nasal spray, compare the amount charged today with the amount charged later, the number of months purchased, the renewal date, the cancellation window, and the refund boundary after clinical or pharmacy processing. A published price cannot safely answer those policy questions unless the cited provider evidence does.
How to interpret the current offer: bmiMD
bmiMD lists NAD+ nasal spray at $159 a month, continuing, checked 25 October 2026. Read the amount together with the billing interval and any promotion or prepayment shown beside it. A lower monthly equivalent may require a longer commitment and a larger charge today. The linked price source is dated evidence of the advertised offer, not an independently verified checkout total or a guarantee that every dose and plan costs the same.
The published price includes medication. It does not verify that labs, every consultation, supplies, expedited shipping, or future dose changes are included unless the source says so. Those items remain checkout questions. For bmiMD NAD+ nasal spray, read medication inclusion as one part of the offer, not as proof that every service surrounding the prescription is free. The dated source establishes the advertised basis; it does not independently audit the final checkout, dispensing event, or quality of care.
The exact product and what it does not establish: NAD+ nasal spray
NAD+ nasal spray is listed as a compounded product in Intranasal spray format. FDA states that compounded drugs are not FDA-approved and do not receive the same premarket review as approved drug products. Ask for the exact formulation and dispensing pharmacy before purchase. That status is central to this bmiMD guide because a related medication name does not make branded, compounded, oral, nasal, and injectable products interchangeable.
bmiMD lists NAD+ nasal spray in Intranasal spray format. The Compounded NAD+ nasal spray comparison groups offers with the same treatment and route so their prices can be assessed fairly. A shared medication name does not make different formulations interchangeable. This guide does not provide dose instructions or route conversions, and it does not establish that another formulation has the same evidence, safety profile, convenience or outcomes.
Operational evidence worth carrying forward: bmiMD
The linked sources identify Precision Compounding Pharmacy as bmiMD's pharmacy. Quoted from the terms: "Precision Compounding Pharmacy – 2657 Merrick Road, Bellmore, NY 11710". The same section says prescriptions come from licensed 503A compounding pharmacies, the specific pharmacy can vary by state, and patients may select an alternate pharmacy. These entities can perform different jobs, so the consumer-facing brand should not automatically be described as the clinician or dispensing pharmacy for NAD+ nasal spray.
Shipping: Product pages and the homepage state free shipping on subscription orders. How-it-works says medication and supplies ship from a U.S.-based licensed partner pharmacy. No numeric delivery window is published. An unresolved issue for bmiMD's NAD+ nasal spray offer remains: HIPAA-compliant chat versus not a covered entity: Marketing pages display a HIPAA-compliant chat badge. The terms say Medccm Inc is not a HIPAA covered entity, while a healthcare provider consulted through the Service may be. Ask the provider how that issue affects the selected order. A published price does not resolve uncertainty about billing, fulfillment, eligibility or the terms that apply after payment.
Availability and its limits: NAD+ nasal spray
Telehealth Ledger has not verified nationwide availability for this nad offer. Missing state restrictions do not establish nationwide service. Confirm that this treatment can be prescribed and shipped to the actual state before intake. The NAD+ nasal spray access check belongs near the price because a low published figure has little decision value when bmiMD cannot serve the reader's state or the selected product cannot be fulfilled there.
For bmiMD NAD+ nasal spray, the consumer brand, administrative platform, clinical group, and dispensing pharmacy can be different entities. A provider page may describe a national service while licensure, product rules, and pharmacy coverage narrow actual fulfillment. Ask which clinician entity would review the intake and which licensed pharmacy would dispense this exact product in the reader's state before treating access as settled.
Move from this guide to the full comparison: NAD+ nasal spray
The linked NAD+ nasal spray comparison places bmiMD beside other providers with published prices. Check the same details for every offer: continuing price, introductory period, required prepayment, medication inclusion, product type, delivery format, verification date, and state evidence. If two offers use different routes or one price excludes medication, a simple lowest-number verdict would not be a like-for-like conclusion.
Use the comparison link to check other NAD+ nasal spray offers, then open bmiMD's site to confirm the selected product. A provider may list several related treatments or plan lengths on the same page. Make sure the intake and checkout still name NAD+ nasal spray, use the intranasal spray format, and show the same medication inclusion and billing basis before treating the two offers as equivalent.
Decision summary: bmiMD NAD+ nasal spray
The responsible verdict is conditional: bmiMD has a source-backed NAD+ nasal spray offer, while the final purchase decision still depends on current checkout terms, state access, clinical review, and dispensing details.
Readers comparing nasal NAD who need bmiMD's spray format and current terms isolated from its injectable catalog. If the provider page or checkout disagrees with the dated information here, ask for the current product, total charge and renewal terms in writing. Resolve the difference before paying instead of relying on the older figure.
bmiMD NAD+ nasal spray FAQ
- What amount is currently published for bmiMD NAD+ nasal spray?
- The linked price source lists $159 a month, continuing for NAD+ nasal spray, checked 25 October 2026. The amount should be read with any introduction, prepayment, or commitment shown in the same offer record. It is a dated published commercial fact, not a promise that every checkout configuration, future renewal, or product change will cost the same amount.
- What must checkout confirm in the bmiMD figure?
- The published bmiMD offer includes medication for NAD+ nasal spray. That does not establish that the price includes labs, every consultation, supplies, faster shipping, dose-related price changes, or a future refill. Confirm those items and the complete charge in the selected checkout before treating the figure as all-inclusive.
- Does this guide cover other formulations for bmiMD NAD+ nasal spray?
- This guide covers NAD+ nasal spray in Intranasal spray format. It does not transfer price, regulatory status, evidence, convenience, dosing, pharmacy, or fulfillment claims to another NAD+ nasal spray formulation or to a related product. Compare route and product identity before comparing the price because similar medication names can still describe materially different offers.
- Is access guaranteed for bmiMD NAD+ nasal spray?
- Nationwide availability has not been verified for this offer. Confirm current state eligibility before relying on the offer. A published state list is only one part of eligibility. bmiMD must also confirm clinician licensure, product eligibility, and pharmacy fulfillment for the specific NAD+ nasal spray prescription. Completing an intake does not guarantee approval, dispensing, or a particular outcome.
- Where can I compare current provider prices for bmiMD NAD+ nasal spray?
- Use the NAD+ nasal spray comparison to check the dated prices, product formats and plan terms across providers. Compare bmiMD only with offers that disclose the same price components, medication inclusion, commitment, and format; otherwise explain why the rows are not directly equivalent.
Sources and method
Telehealth Ledger checked provider pages, plan terms, and independent context on 25 October 2026. This page compares published commercial terms. It is not a rating, medical advice, or a guarantee that a clinician will prescribe treatment.
- bmiMD NAD+ nasal spray product page
- bmiMD official website
- bmiMD homepage
- bmiMD product-page LegitScript seal
- bmiMD compounded tirzepatide product page
- bmiMD compounded semaglutide shopping lander
- bmiMD compounded tirzepatide shopping lander
- bmiMD oral tirzepatide assigned landing
- bmiMD compounded semaglutide microdose page
- bmiMD compounded tirzepatide microdose page
- bmiMD NAD+ injection product page
- bmiMD glutathione injection product page
- bmiMD sermorelin injection product page
- bmiMD sermorelin tablet product page
- bmiMD sermorelin nasal spray product page
- bmiMD metformin product page
- bmiMD MIC+B12 injection product page
- bmiMD naltrexone, bupropion, and B6 product page
- bmiMD how-it-works page
- bmiMD terms of use
- bmiMD return and refund policy
- bmiMD HSA/FSA page
- Trustpilot profile for bmimd.com
- BBB profile for bmiMD / MEDCCM, Inc.
- FDA reminder on ingredients suitable for sterile compounding
- FDA questions and answers about drug compounding
- FDA overview of compounded-drug risks
